Efficacy and safety of eribulin in patients with locally advanced or metastatic breast cancer not meeting trial eligibility criteria: a retrospective study

BACKGROUND: The efficacy and safety of eribulin in patients with locally advanced or metastatic breast cancer has been demonstrated in phase III trials. However, as patients receiving eribulin in daily practice do not necessarily meet all the eligibility criteria of clinical trials, data for such pa...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:BMC Cancer
Main Authors: Iizumi, Sakura, Shimoi, Tatsunori, Tsushita, Natsuko, Bun, Seiko, Shimomura, Akihiko, Noguchi, Emi, Kodaira, Makoto, Yunokawa, Mayu, Yonemori, Kan, Shimizu, Chikako, Fujiwara, Yasuhiro, Tamura, Kenji
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2017
Teme:
Research Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5716387/
https://ncbi.nlm.nih.gov/pubmed/29202787
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-017-3846-8
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki